The NADA Practice Leadership Group met in June 2019 to finalise the action plan for 2018–2020.
Highlighted at the meeting and in the plan, the NPLG:
emphasise the importance of the consumer voice and the necessity of embedding consumer participation in all areas of clinical practice and therapeutic work
support the recent Cognitive Remediation study conducted by the ACI that shines a light on the importance of targeted intervention strategies for cognitive impaired clients
seek to continue representing and advocating for the sector at Quality in Treatment meetings.
The NPLG is helping to shape the NADA Conference in 2020, and is looking to focus on inclusive practice with future thought to innovation. We would like to thank Jesse Taylor and Jessica Burgess who stepped down from their positions in the NPLG and wish them all the best in their future plans.
Ask the NPLG for advice
Help your service deliver person centred and evidence based practices to improve the wellbeing of clients and their networks of support. Learn about each member, their area of expertise and their interest. Email NPLG@nada.org.au or phone Suzie Hudson on 8113 1309 to ask for support.
Enhancing clinical practice—3 May 2017
Connecting clinical practice leaders in the NSW non government alcohol and other drug sector for the purpose of increasing the capacity of service providers to deliver person centred, evidence based practices to improve the wellbeing of clients and their networks of support.
The NPLG was established in July 2015 and now comprise 11 members representing a variety of specialist non government AOD treatment services. All members are clinical practitioners and considered leaders in the sector as evidenced by their professional backgrounds, accreditation status and clinical experience.
The group meet four times a year and meetings are open to other members/organisations as guest speakers only by invitation.
The overall aim of the NPLG is to inform the development of NADA policy and advocacy, and sector program development in relation to sector clinical and therapeutic practices. It will provide a mechanism to consult with experienced, committed and skilled practitioners to advise NADA and other key stakeholders.